Virology, immunology and pathology of human rabies during treatment.

PubWeight™: 2.06‹?› | Rank: Top 2%

🔗 View Article (PMID 25405805)

Published in Pediatr Infect Dis J on May 01, 2015

Authors

Yolanda Caicedo1, Andres Paez, Ivan Kuzmin, Michael Niezgoda, Lillian A Orciari, Pamela A Yager, Sergio Recuenco, Richard Franka, Andres Velasco-Villa, Rodney E Willoughby

Author Affiliations

1: From the *Hospital Universitario del Valle, Cali, Colombia; †Laboratorio de Virología, Instituto Nacional de Salud (INS), Bogotá D.C., Colombia; ‡Rabies Program, Centers for Disease Control and Prevention, Atlanta, GA; §Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention, Atlanta, GA; and ¶Medical College of Wisconsin, Milwaukee, WI.

Articles cited by this

MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97

Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ (2005) 11.02

Survival after treatment of rabies with induction of coma. N Engl J Med (2005) 4.95

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15

Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis (2006) 1.82

Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab (2003) 1.71

Comparative study of abortive and nonabortive rabies in mice. J Infect Dis (1969) 1.62

Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A (1992) 1.60

Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis (2008) 1.56

MR imaging in human rabies. AJNR Am J Neuroradiol (2003) 1.48

Human rabies. Diagnosis, complications, and management. Am J Dis Child (1974) 1.28

A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis (1970) 1.24

Pasteur and parachutes: when statistical process control is better than a randomized controlled trial. Qual Saf Health Care (2005) 1.22

Human rabies encephalomyelitis. Br Med J (1976) 1.15

Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci U S A (2008) 1.14

Isolation of Lagos bat virus from water mongoose. Emerg Infect Dis (2006) 1.12

Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol (2008) 1.10

Recovery of a patient from clinical rabies--California, 2011. MMWR Morb Mortal Wkly Rep (2012) 1.09

Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke (1989) 1.07

A case of human rabies with prolonged survival. Intervirology (1973) 1.04

Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine (2006) 1.02

Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies. J Neurovirol (2008) 0.99

Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res (2012) 0.95

The clinical picture of rabies in man. Trans R Soc Trop Med Hyg (1976) 0.95

Isolation of rabies virus outside the human central nervous system. J Infect Dis (1973) 0.92

Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts. Curr Infect Dis Rep (2012) 0.92

Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis (2011) 0.91

Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol (2010) 0.91

Comparison of rabies humoral antibody titers in rabbits and humans by indirect radioimmunoassay, rapid-fluorescent-focus-inhibition technique, and indirect fluorescent-antibody assay. J Clin Microbiol (1977) 0.90

Human rabies encephalitis following bat exposure: failure of therapeutic coma. CMAJ (2008) 0.89

Presumptive abortive human rabies - Texas, 2009. MMWR Morb Mortal Wkly Rep (2010) 0.89

Survival of a rabies patient. Indian Pediatr (2011) 0.89

Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke (2003) 0.86

Recovery from and clearance of rabies virus in a domestic ferret. J Am Assoc Lab Anim Sci (2011) 0.85

Presence of cross-reactions with other viral encephalitides in the indirect fluorescent-antibody test for diagnosis of rabies. J Clin Microbiol (2013) 0.81

Massive necrosis of the brain in rabies. Can J Neurol Sci (1987) 0.79

Articles by these authors

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49

New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis (2002) 2.50

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep (2010) 2.31

Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J (2010) 2.07

Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg Infect Dis (2009) 2.04

Lagos bat virus in Kenya. J Clin Microbiol (2008) 2.00

Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res (2003) 1.98

Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc Natl Acad Sci U S A (2013) 1.93

Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis (2006) 1.82

Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res (2005) 1.75

Raccoon rabies virus variant transmission through solid organ transplantation. JAMA (2013) 1.71

Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res (2010) 1.71

Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria. MBio (2010) 1.62

Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States. Emerg Infect Dis (2008) 1.52

Oral rabies vaccination in north america: opportunities, complexities, and challenges. PLoS Negl Trop Dis (2009) 1.48

Clostridium difficile infection in infants and children. Pediatrics (2012) 1.48

Molecular diversity of rabies viruses associated with bats in Mexico and other countries of the Americas. J Clin Microbiol (2006) 1.46

Survey for bat lyssaviruses, Thailand. Emerg Infect Dis (2005) 1.45

A clustering of immune-mediated polyradiculoneuropathy among swine abattoir workers exposed to aerosolized porcine brains, Indiana, United States. Int J Occup Environ Health (2009) 1.44

Ecological and anthropogenic drivers of rabies exposure in vampire bats: implications for transmission and control. Proc Biol Sci (2012) 1.42

Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies. Ann Neurol (2014) 1.40

Rabies diagnosis for developing countries. PLoS Negl Trop Dis (2008) 1.36

Bartonella spp. in bats, Kenya. Emerg Infect Dis (2010) 1.36

Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009. PLoS Pathog (2012) 1.31

Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J Gen Virol (2005) 1.28

Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis (2002) 1.27

Evidence of rabies virus exposure among humans in the Peruvian Amazon. Am J Trop Med Hyg (2012) 1.26

Investigation of the role of healthy dogs as potential carriers of rabies virus. Vector Borne Zoonotic Dis (2008) 1.25

Emerging pattern of rabies deaths and increased viral infectivity. Emerg Infect Dis (2003) 1.24

Molecular epidemiology of terrestrial rabies in the former Soviet Union. J Wildl Dis (2004) 1.23

Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol (2005) 1.22

Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis (2009) 1.21

Bartonella spp. in Bats, Guatemala. Emerg Infect Dis (2011) 1.19

Possible emergence of West Caucasian bat virus in Africa. Emerg Infect Dis (2008) 1.18

Rates of viral evolution are linked to host geography in bat rabies. PLoS Pathog (2012) 1.15

Isolation of Lagos bat virus from water mongoose. Emerg Infect Dis (2006) 1.12

Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses (2009) 1.09

Experimental rabies virus infection of big brown bats (Eptesicus fuscus). J Wildl Dis (2008) 1.08

Molecular epidemiology of rabies in Southern People's Republic of China. Emerg Infect Dis (2009) 1.08

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis (2006) 1.06

Enzootic and epizootic rabies associated with vampire bats, peru. Emerg Infect Dis (2013) 1.06

Genetic divergence of rabies viruses from bat species of Colorado, USA. Vector Borne Zoonotic Dis (2005) 1.05

Prevention of necrotizing enterocolitis with probiotics. Pediatrics (2005) 1.04

Reassortant group A rotavirus from straw-colored fruit bat (Eidolon helvum). Emerg Infect Dis (2010) 1.04

Prevalence and diversity of Bartonella spp. in bats in Peru. Am J Trop Med Hyg (2012) 1.03

Genetic characterization of atypical Mansonella (Mansonella) ozzardi microfilariae in human blood samples from northeastern Peru. Am J Trop Med Hyg (2012) 1.03

Isolation and molecular characterization of Fikirini rhabdovirus, a novel virus from a Kenyan bat. J Gen Virol (2013) 1.03

Human rabies and rabies in vampire and nonvampire bat species, Southeastern Peru, 2007. Emerg Infect Dis (2009) 1.02

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine (2009) 1.02

Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res (2005) 1.01

Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol (2005) 1.00

Marburg virus in fruit bat, Kenya. Emerg Infect Dis (2010) 1.00

Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses (2010) 1.00

Overview: infection during pregnancy and neurologic outcome in the child. Ment Retard Dev Disabil Res Rev (2002) 0.98

Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies. J Infect Dis (2003) 0.98

Discovery of diverse polyomaviruses in bats and the evolutionary history of the Polyomaviridae. J Gen Virol (2012) 0.98

Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury. Ann Clin Microbiol Antimicrob (2006) 0.96

Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons. J Wildl Dis (2002) 0.96

Correction: Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis (2015) 0.96

Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Vaccine (2009) 0.96

Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res (2012) 0.95

Intrauterine exposure to infection and risk of cerebral palsy in very preterm infants. Arch Pediatr Adolesc Med (2003) 0.95

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine (2006) 0.95

Current and future tools for global canine rabies elimination. Antiviral Res (2013) 0.95

Ferret badger rabies origin and its revisited importance as potential source of rabies transmission in Southeast China. BMC Infect Dis (2010) 0.94

Are all lyssavirus genes equal for phylogenetic analyses? Virus Res (2007) 0.94

Postexposure prophylaxis for prevention of rabies in dogs. Am J Vet Res (2002) 0.94

Rabies-related knowledge and practices among persons at risk of bat exposures in Thailand. PLoS Negl Trop Dis (2011) 0.93

Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines. Vaccine (2007) 0.93

The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers. J Travel Med (2013) 0.92

Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis (2011) 0.91

Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis (2009) 0.91

Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res (2005) 0.90

Pilot study of antibiotic cycling in a pediatric intensive care unit. Crit Care Med (2002) 0.89

Lyssavirus surveillance in bats, Bangladesh. Emerg Infect Dis (2006) 0.88